Stephens Kristin Insider Trades

Insider Trading History

Track insider trading activity for Stephens Kristin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Nov 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.18k 36,133 shares
$0.20
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $14.5 36,133 shares
Last Trade
Oct 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.4k 6,104 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Oct 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.8k 17,000 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $16.9 42,237 shares
Last Trade
Oct 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.8k 17,000 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $10.1 25,237 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.6k 4,218 shares
$5.12
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $6.32 15,789 shares
Last Trade
Nov 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.6k 5,676 shares
$2.22
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $6.8 17,000 shares
Last Trade
Oct 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.3k 17,000 shares
$2.49
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $8.59 21,465 shares
Last Trade
Oct 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.3k 17,000 shares
$2.49
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $1.79 4,465 shares
Last Trade
Apr 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.61k 623 shares
$2.58
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $2.4 6,000 shares
Last Trade
Mar 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34k 2,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $2.04 5,088 shares
Last Trade
Mar 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.34k 2,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $14 35,000 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$141k 35,000 shares
$4.02
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $17.8 44,500 shares
Last Trade
Oct 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$528k 78,500 shares
$6.73
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $12.4 30,885 shares
Last Trade
Apr 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.8k 14,115 shares
$1.12
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $80 200,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$604k 380,000 shares
$1.59
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jun 08, 2021 Sale
$592k 94,000 shares
$6.30
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up